This area is reserved for registered users. Please register or login.

Toujeo – New basal insulin for adults with diabetes

Sanofi is pleased to announce that Toujeo (insulin glargine 300 units/ml), a once-daily long-acting basal insulin, is now available in Ireland for the treatment of adults with diabetes mellitus. In type 1 diabetes mellitus (T1DM), Toujeo must be combined with short-/rapid-acting insulin to cover mealtime insulin requirements. In patients with type 2 diabetes mellitus (T2DM), Toujeo can also be given together with other anti-hyperglycaemics.1   Long-acting basal insulin analogues have contributed significantly to the management of diabetes over the last decade.2 Key hurdles to attain adequate glycaemic control for patients on insulin therapy include regimen complexity and injection frequency, both…